The purpose of this review is to summarize drugs containing an azoloazine moiety and exhibiting antidiabetic activity. The review includes azoloazines active against dipeptidyl peptidase-4, α-glucosidase, and glycogen phosphorylase acting as PPARγ and GPR119 receptor agonists, as well as those inhibiting advanced glycation.
Translated title of the contributionFUSED AZOLOAZINES WITH ANTIDIABETIC ACTIVITY
Original languageRussian
Pages (from-to)2561-2594
Number of pages34
JournalИзвестия Академии наук. Серия химическая
Issue number12
Publication statusPublished - 2022

    GRNTI

  • 31.00.00 CHEMISTRY

    Level of Research Output

  • Russian Science Citation Index
  • VAK List

ID: 34026629